These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 38468464)

  • 1. GINS1 promotes ZEB1-mediated epithelial-mesenchymal transition and tumor metastasis via β-catenin signaling in hepatocellular carcinoma.
    Liang J; Yao N; Deng B; Li J; Jiang Y; Liu T; Hu Y; Cao M; Hong J
    J Cell Physiol; 2024 May; 239(5):e31237. PubMed ID: 38468464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA HULC enhances epithelial-mesenchymal transition to promote tumorigenesis and metastasis of hepatocellular carcinoma via the miR-200a-3p/ZEB1 signaling pathway.
    Li SP; Xu HX; Yu Y; He JD; Wang Z; Xu YJ; Wang CY; Zhang HM; Zhang RX; Zhang JJ; Yao Z; Shen ZY
    Oncotarget; 2016 Jul; 7(27):42431-42446. PubMed ID: 27285757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ARHGEF11 promotes proliferation and epithelial-mesenchymal transition of hepatocellular carcinoma through activation of β-catenin pathway.
    Du J; Zhu Z; Xu L; Chen X; Li X; Lan T; Li W; Yuan K; Zeng Y
    Aging (Albany NY); 2020 Oct; 12(20):20235-20253. PubMed ID: 33122451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HEG1 indicates poor prognosis and promotes hepatocellular carcinoma invasion, metastasis, and EMT by activating Wnt/β-catenin signaling.
    Zhao YR; Wang JL; Xu C; Li YM; Sun B; Yang LY
    Clin Sci (Lond); 2019 Jul; 133(14):1645-1662. PubMed ID: 31278131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TXNDC12 promotes EMT and metastasis of hepatocellular carcinoma cells via activation of β-catenin.
    Yuan K; Xie K; Lan T; Xu L; Chen X; Li X; Liao M; Li J; Huang J; Zeng Y; Wu H
    Cell Death Differ; 2020 Apr; 27(4):1355-1368. PubMed ID: 31570854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FAM134B induces tumorigenesis and epithelial-to-mesenchymal transition via Akt signaling in hepatocellular carcinoma.
    Zhang ZQ; Chen J; Huang WQ; Ning D; Liu QM; Wang C; Zhang L; Ren L; Chu L; Liang HF; Fan HN; Zhang BX; Chen XP
    Mol Oncol; 2019 Apr; 13(4):792-810. PubMed ID: 30556279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NCSTN promotes hepatocellular carcinoma cell growth and metastasis via β-catenin activation in a Notch1/AKT dependent manner.
    Li H; Lan T; Xu L; Liu H; Wang J; Li J; Chen X; Huang J; Li X; Yuan K; Zeng Y; Wu H
    J Exp Clin Cancer Res; 2020 Jul; 39(1):128. PubMed ID: 32631394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KIAA1217 Promotes Epithelial-Mesenchymal Transition and Hepatocellular Carcinoma Metastasis by Interacting with and Activating STAT3.
    Wang Y; Li N; Zheng Y; Wang A; Yu C; Song Z; Wang S; Sun Y; Zheng L; Wang G; Liu L; Yi J; Huang Y; Zhang M; Bao Y; Sun L
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deregulated AJAP1/β-catenin/ZEB1 signaling promotes hepatocellular carcinoma carcinogenesis and metastasis.
    Han J; Xie C; Pei T; Wang J; Lan Y; Huang K; Cui Y; Wang F; Zhang J; Pan S; Liang Y; Zhen T; Song R; Sun B; Li Y; Shi H; Yang G; Liu X; Zhu M; Wang Y; Li K; Liu Y; Meng F; Liao F; Meng X; Hong X; Liu L
    Cell Death Dis; 2017 Apr; 8(4):e2736. PubMed ID: 28383563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of IQGAP3 in metastasis and epithelial-mesenchymal transition in human hepatocellular carcinoma.
    Shi Y; Qin N; Zhou Q; Chen Y; Huang S; Chen B; Shen G; Jia H
    J Transl Med; 2017 Aug; 15(1):176. PubMed ID: 28810875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of SNHG6 regulates ZEB1 expression by competitively binding miR-101-3p and interacting with UPF1 in hepatocellular carcinoma.
    Chang L; Yuan Y; Li C; Guo T; Qi H; Xiao Y; Dong X; Liu Z; Liu Q
    Cancer Lett; 2016 Dec; 383(2):183-194. PubMed ID: 27702662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Galectin-3 favours tumour metastasis via the activation of β-catenin signalling in hepatocellular carcinoma.
    Song M; Pan Q; Yang J; He J; Zeng J; Cheng S; Huang Y; Zhou ZQ; Zhu Q; Yang C; Han Y; Tang Y; Chen H; Weng DS; Xia JC
    Br J Cancer; 2020 Nov; 123(10):1521-1534. PubMed ID: 32801345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological significance of ZEB1 protein in patients with hepatocellular carcinoma.
    Zhou YM; Cao L; Li B; Zhang RX; Sui CJ; Yin ZF; Yang JM
    Ann Surg Oncol; 2012 May; 19(5):1700-6. PubMed ID: 21584833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. lncRNA TUG1-Mediated Mir-142-3p Downregulation Contributes to Metastasis and the Epithelial-to-Mesenchymal Transition of Hepatocellular Carcinoma by Targeting ZEB1.
    He C; Liu Z; Jin L; Zhang F; Peng X; Xiao Y; Wang X; Lyu Q; Cai X
    Cell Physiol Biochem; 2018; 48(5):1928-1941. PubMed ID: 30092578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type IIA topoisomerase (TOP2A) triggers epithelial-mesenchymal transition and facilitates HCC progression by regulating Snail expression.
    Dong Y; Sun X; Zhang K; He X; Zhang Q; Song H; Xu M; Lu H; Ren R
    Bioengineered; 2021 Dec; 12(2):12967-12979. PubMed ID: 34939898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-122 inhibits epithelial-mesenchymal transition in hepatocellular carcinoma by targeting Snail1 and Snail2 and suppressing WNT/β-cadherin signaling pathway.
    Jin Y; Wang J; Han J; Luo D; Sun Z
    Exp Cell Res; 2017 Nov; 360(2):210-217. PubMed ID: 28890291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Actin-like 6A predicts poor prognosis of hepatocellular carcinoma and promotes metastasis and epithelial-mesenchymal transition.
    Xiao S; Chang RM; Yang MY; Lei X; Liu X; Gao WB; Xiao JL; Yang LY
    Hepatology; 2016 Apr; 63(4):1256-71. PubMed ID: 26698646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PRRX1 deficiency induces mesenchymal-epithelial transition through PITX2/miR-200-dependent SLUG/CTNNB1 regulation in hepatocellular carcinoma.
    Chen W; Wu J; Shi W; Zhang G; Chen X; Ji A; Wang Z; Wu J; Jiang C
    Cancer Sci; 2021 Jun; 112(6):2158-2172. PubMed ID: 33587761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metadherin promotes hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition.
    Zhu K; Dai Z; Pan Q; Wang Z; Yang GH; Yu L; Ding ZB; Shi GM; Ke AW; Yang XR; Tao ZH; Zhao YM; Qin Y; Zeng HY; Tang ZY; Fan J; Zhou J
    Clin Cancer Res; 2011 Dec; 17(23):7294-302. PubMed ID: 21976539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Programmed cell death 10 promotes metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma via PP2Ac-mediated YAP activation.
    Sun B; Zhong FJ; Xu C; Li YM; Zhao YR; Cao MM; Yang LY
    Cell Death Dis; 2021 Sep; 12(9):849. PubMed ID: 34521817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.